Free Trial

BioCryst Pharmaceuticals (BCRX) Institutional Ownership

BioCryst Pharmaceuticals logo
$7.31 -0.07 (-0.95%)
(As of 11:21 AM ET)

Institutional Ownership Changes (13F Filings) for BioCryst Pharmaceuticals (NASDAQ:BCRX)

Current
Institutional Ownership
Percentage
85.88%
Number of
Institutional Buyers
(last 12 months)
86
Total
Institutional Inflows
(last 12 months)
$133.16M
Number of
Institutional Sellers
(last 12 months)
47
Total
Institutional Outflows
(last 12 months)
$57.24M
Get BCRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling BioCryst Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

BCRX Institutional Buying and Selling by Quarter

BioCryst Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/27/2024 Franklin Resources Inc.263,748$1.97M0.0%+177.8%0.127%
11/25/2024 Sanctuary Advisors LLC47,389$360K0.0%+78.3%0.023%
11/21/2024 SkyView Investment Advisors LLC13,000$99K0.0%+30.0%0.006%
11/18/2024 Arete Wealth Advisors LLC12,050$92K0.0%-45.7%0.006%
11/16/2024 Geode Capital Management LLC4,837,985$36.78M0.0%+2.7%2.336%
11/15/2024 Y Intercept Hong Kong Ltd83,123$632K0.0%-7.0%0.040%
11/15/2024 XTX Topco Ltd31,670$241K0.0%-79.8%0.015%
11/15/2024 Wellington Management Group LLP107,820$819K0.0%N/A0.052%
11/15/2024 Two Sigma Advisers LP2,181,012$16.58M0.0%+13.6%1.053%
11/15/2024 State Street Corp8,849,588$67.26M0.0%-5.3%4.272%
11/15/2024 Quantinno Capital Management LP10,731$82K0.0%N/A0.005%
11/15/2024 Parkman Healthcare Partners LLC464,048$3.53M0.5%+15.9%0.224%
11/15/2024 Jacobs Levy Equity Management Inc.367,514$2.79M0.0%-50.3%0.177%
11/15/2024 Cinctive Capital Management LP273,959$2.08M0.1%N/A0.132%
11/15/2024 Erste Asset Management GmbH40,000$305K0.0%N/A0.019%
11/14/2024 Caligan Partners LP2,583,585$19.64M6.2%-43.8%1.247%
11/14/2024 PDT Partners LLC522,280$3.97M0.4%+42.4%0.252%
11/14/2024 Verition Fund Management LLC39,520$300K0.0%-72.2%0.019%
11/14/2024 Captrust Financial Advisors16,274$124K0.0%+19.4%0.008%
11/14/2024 Rockefeller Capital Management L.P.26,400$201K0.0%N/A0.013%
11/14/2024 Alkeon Capital Management LLC7,093,822$53.91M0.1%-0.1%3.425%
11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC389,530$2.96M0.0%-10.0%0.188%
11/14/2024 Zurcher Kantonalbank Zurich Cantonalbank 51,012$388K0.0%+7.7%0.025%
11/13/2024 BNP Paribas Financial Markets496,784$3.78M0.0%+472.0%0.240%
11/13/2024 FMR LLC1,988,389$15.11M0.0%+2.4%0.960%
11/13/2024 The Manufacturers Life Insurance Company 299,152$2.27M0.0%+40.7%0.144%
11/13/2024 Dynamic Technology Lab Private Ltd11,352$86K0.0%-71.7%0.005%
11/13/2024Fisher Asset Management LLC3,338,062$25.37M0.0%+16.9%1.612%
11/12/2024 Alpha DNA Investment Management LLC58,898$448K0.2%N/A0.028%
11/12/2024 Algert Global LLC516,209$3.92M0.1%+46.2%0.249%
11/12/2024 Charles Schwab Investment Management Inc.1,887,994$14.35M0.0%+5.8%0.912%
11/9/2024 Intech Investment Management LLC54,237$412K0.0%N/A0.026%
11/8/2024 Connor Clark & Lunn Investment Management Ltd.682,324$5.19M0.0%-12.8%0.330%
11/8/2024 Segall Bryant & Hamill LLC1,490,376$11.33M0.2%-2.4%0.720%
11/8/2024 Counterweight Ventures LLC93,384$710K0.5%+591.7%0.045%
11/6/2024 KBC Group NV5,661$43K0.0%-34.4%0.003%
11/5/2024 Aigen Investment Management LP28,661$218K0.0%+75.0%0.014%
11/5/2024 GSA Capital Partners LLP285,588$2.17M0.2%-21.5%0.138%
11/4/2024 Los Angeles Capital Management LLC86,533$658K0.0%-11.3%0.042%
10/31/2024 Principal Financial Group Inc.411,414$3.13M0.0%+1,058.1%0.199%
Why I'm telling friends to avoid gold stocks (Ad)

Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."

And if you’d like to get your hands on this, here you go, the complete breakdown.
10/28/2024 Rice Hall James & Associates LLC2,163,743$16.44M0.9%+4.0%1.048%
10/25/2024 China Universal Asset Management Co. Ltd.39,791$302K0.0%+64.1%0.019%
10/24/2024 Semanteon Capital Management LP149,576$1.14M0.8%N/A0.072%
10/24/2024 Wealth Enhancement Advisory Services LLC17,344$132K0.0%+44.5%0.008%
10/23/2024 Mirae Asset Global Investments Co. Ltd.7,483$57K0.0%+21.5%0.004%
10/23/2024 Assenagon Asset Management S.A.14,071$107K0.0%-78.3%0.007%
10/16/2024 nVerses Capital LLC15,500$118K0.1%+52.0%0.008%
10/11/2024 Creative Planning49,347$375K0.0%+5.9%0.024%
10/10/2024 Inspire Investing LLC158,008$1.20M0.1%+174.6%0.077%
10/8/2024 CWM LLC17,072$130K0.0%+201.7%0.008%
10/7/2024 Diversified Trust Co21,680$165K0.0%-12.4%0.011%
10/3/2024 SG Americas Securities LLC158,921$1.21M0.0%N/A0.077%
9/5/2024 Sanctuary Advisors LLC26,571$164K0.0%N/A0.013%
8/16/2024 Northeast Financial Consultants Inc65,633$406K0.0%+8.2%0.032%
8/16/2024 Creative Planning46,613$288K0.0%+75.2%0.023%
8/16/2024 Algert Global LLC353,133$2.18M0.1%+18.6%0.171%
8/15/2024Susquehanna Fundamental Investments LLC30,176$186K0.0%-53.1%0.015%
8/15/2024 Mackenzie Financial Corp27,913$173K0.0%-13.5%0.014%
8/15/2024 The Manufacturers Life Insurance Company212,581$1.31M0.0%+113.8%0.103%
8/15/2024 Millennium Management LLC1,751,561$10.83M0.0%-13.8%0.849%
8/15/2024 Deerfield Management Company L.P. Series C8,135,804$50.28M0.8%+62.9%3.942%
8/15/2024 AQR Capital Management LLC543,241$3.36M0.0%+18.8%0.263%
8/15/2024 ELCO Management Co. LLC30,792$190K0.1%-14.5%0.015%
8/15/2024 Point72 Asia Singapore Pte. Ltd.72,666$449K0.1%N/A0.035%
8/15/2024 Point72 Europe London LLP267,649$1.65M0.1%N/A0.130%
8/14/2024 Cubist Systematic Strategies LLC1,112,232$6.87M0.0%+528.0%0.538%
8/14/2024 Point72 DIFC Ltd66,564$411K0.0%+598.2%0.032%
8/14/2024 Xponance Inc.12,980$80K0.0%+13.1%0.006%
8/14/2024 Avoro Capital Advisors LLC12,570,000$77.68M1.0%-3.7%6.091%
8/14/2024 DRW Securities LLC11,987$74K0.0%N/A0.006%
8/14/2024 ProShare Advisors LLC38,128$236K0.0%-21.4%0.018%
8/14/2024 Profund Advisors LLC86,815$537K0.0%-64.1%0.042%
8/12/2024 Inspire Investing LLC57,550$356K0.0%-17.2%0.028%
8/12/2024 XTX Topco Ltd156,946$970K0.1%+299.0%0.076%
8/12/2024 Seven Eight Capital LP169,612$1.05M0.1%+1,407.1%0.082%
8/12/2024 Hsbc Holdings PLC125,004$759K0.0%+32.7%0.061%
8/12/2024 E Fund Management Co. Ltd.28,285$175K0.0%-61.9%0.014%
8/9/2024 Renaissance Technologies LLC960,180$5.93M0.0%-39.6%0.465%
8/8/2024 American Century Companies Inc.148,490$918K0.0%+896.6%0.072%
8/8/2024 Rice Hall James & Associates LLC2,079,641$12.85M0.8%-3.3%1.008%
8/7/2024 Headlands Technologies LLC16,750$104K0.0%N/A0.008%
8/6/2024 Los Angeles Capital Management LLC97,577$603K0.0%+8.9%0.047%
8/3/2024 TD Asset Management Inc240,600$1.49M0.0%N/A0.117%
8/1/2024 Rhumbline Advisers318,665$1.97M0.0%+6.3%0.154%
7/31/2024 nVerses Capital LLC10,200$63K0.0%N/A0.005%
7/31/2024Commonwealth Equity Services LLC143,874$889K0.0%-1.0%0.070%
7/30/2024 Signaturefd LLC6,598$41K0.0%+560.5%0.003%
7/29/2024 Principal Financial Group Inc.35,524$220K0.0%-26.3%0.017%
7/29/2024 Panagora Asset Management Inc.650,318$4.02M0.0%+2.8%0.315%
7/27/2024 Leisure Capital Management28,000$173K0.1%N/A0.014%
Why I'm telling friends to avoid gold stocks (Ad)

Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."

And if you’d like to get your hands on this, here you go, the complete breakdown.
7/26/2024 Bank of New York Mellon Corp775,957$4.80M0.0%+12.5%0.376%
7/18/2024 Assenagon Asset Management S.A.64,907$401K0.0%-83.2%0.031%
7/16/2024 Diversified Trust Co24,752$153K0.0%+18.0%0.012%
7/10/2024 CWM LLC5,658$35K0.0%+200.0%0.003%
5/17/2024 Tidal Investments LLC55,560$282K0.0%N/A0.027%
5/16/2024 Redwood Investment Management LLC122,270$621K0.1%N/A0.059%
5/16/2024 California State Teachers Retirement System184,788$939K0.0%-7.6%0.090%
5/16/2024 Jacobs Levy Equity Management Inc.156,119$793K0.0%+62.0%0.076%
5/16/2024 Kynam Capital Management LP6,527,491$33.16M3.5%+41.9%3.163%
5/15/2024 Sarissa Capital Management LP1,094,168$5.56M1.0%+9.4%0.530%
(Data available from 1/1/2016 forward)

BCRX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of BCRX shares?

During the previous two years, 181 institutional investors and hedge funds held shares of BioCryst Pharmaceuticals. The most heavily invested institutionals were Vanguard Group Inc. ($89.80M), Avoro Capital Advisors LLC ($77.68M), State Street Corp ($67.26M), Alkeon Capital Management LLC ($53.91M), Deerfield Management Company L.P. Series C ($50.28M), Pictet Asset Management SA ($46.86M), and Geode Capital Management LLC ($36.78M).Learn more on BCRX's institutional investors.

What percentage of BioCryst Pharmaceuticals stock is owned by institutional investors?

85.88% of BioCryst Pharmaceuticals stock is owned by institutional investors. Learn more on BCRX's institutional investor holdings.

Which institutional investors have been buying BioCryst Pharmaceuticals stock?

Of the 153 institutional investors that purchased BioCryst Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Kynam Capital Management LP ($5.53M), Deerfield Management Company L.P. Series C ($5.10M), Braidwell LP ($3.77M), Avoro Capital Advisors LLC ($2.87M), Assenagon Asset Management S.A. ($2.74M), Vanguard Group Inc. ($2.67M), and Prosight Management LP ($2.38M).

How much institutional buying is happening at BioCryst Pharmaceuticals?

Institutional investors have bought a total of 48,583,343 shares in the last 24 months. This purchase volume represents approximately $350.81M in transactions.

Which BioCryst Pharmaceuticals major shareholders have been selling company stock?

Of the 75 institutional investors that sold BioCryst Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Assenagon Asset Management S.A. ($5.34M), Victory Capital Management Inc. ($4.49M), Caligan Partners LP ($2.02M), Fisher Asset Management LLC ($1.51M), Jacobs Levy Equity Management Inc. ($1.06M), Renaissance Technologies LLC ($630.20K), and BNP Paribas Financial Markets ($622.38K).

How much institutional selling is happening at BioCryst Pharmaceuticals?

Institutional investors have sold a total of 21,251,553 shares in the last 24 months. This volume of shares sold represents approximately $165.17M in transactions.



This page (NASDAQ:BCRX) was last updated on 12/3/2024 by MarketBeat.com Staff
From Our Partners